Press release
September 29, 2025
Kardigan Announces Presentation of Positive Phase 2a Data for Danicamtiv in Patients with Dilated Cardiomyopathy at HFSA Annual Scientific Meeting 2025
Kardigan, Inc. (KARD)
Data simultaneously published in The Journal of the American College of Cardiology (JACC) Results presented in late-breaking oral session showed danicamtiv was well tolerated with significant improvements in ventricular and atrial function in patients with genetic dilated cardiomyopathy (DCM) Data